Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Topical Pharmaceuticals, Inc.
FDA Inspection
•Topical Pharmaceuticals, Inc.•May 7, 2026

Topical Pharmaceuticals, Inc. – FDA Inspection, May 7, 2026

Record Details

This FDA Inspection record concerns Topical Pharmaceuticals, Inc., with an inspection on May 7, 2026, issued by the Chicago District Office, covering human drugs.

Company
Topical Pharmaceuticals, Inc.
Inspection Date
May 7, 2026
Product Type
Human Drugs
Office
Chicago District Office
People
  • Angela C. Welker (Issuing Officer)
  • Chikitsa S. Patel (Issuing Officer)
  • Gabriel Bermudez-Picart (Company Rep)
  • Scott D. Mcgrew (Issuing Officer)
View Company Profile

ID · 9a90d0fa-f872-4acf-ad47-898cb1d94013

Inspection Facts

Inspection number
1315996
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

11
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.165(a)Testing and release for distribution
  4. 21 CFR 211.180(e)(2)Items to cover on annual reviews
  5. 21 CFR 211.188Prepared for each batch, include complete information
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.22(c)Approve or reject procedures or specs
  8. 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
  9. 21 CFR 211.63Equipment Design, Size and Location
  10. 21 CFR 211.67(b)Written procedures not established/followed

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Topical Pharmaceuticals, Inc.

4
DateClassificationOfficeProject area
June 30, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 6, 2019NAICenter for Food Safety and Applied NutritionFoodborne Biological Hazards
July 7, 2016NAICenter for Drug Evaluation and ResearchUnapproved and Misbranded Drugs
January 18, 2011VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Topical Pharmaceuticals, Inc.
  • FDA Inspection 1173770 - 2022-06-30
  • FDA Inspection 1094010 - 2019-06-06
  • FDA Inspection 977547 - 2016-07-07
  • FDA Inspection 707147 - 2011-01-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Topical Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.